Conference
HGS-ETR1, a fully human agonistic monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1 trial.
Authors
Hirte HW; Hotte SJ; Chen EX; Siu L; Le LH; Lo L; MacLean M; Iacobucci A; Fox NL; Oza AM
Volume
11
Pagination
pp. 9104S-9104S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
December 15, 2005
Name of conference
AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference place
Philadelphia, PA
Conference start date
November 14, 2005
Conference end date
November 18, 2005
Conference proceedings
CLINICAL CANCER RESEARCH
Issue
24
ISSN
1078-0432